InvestorsHub Logo
Followers 0
Posts 36
Boards Moderated 0
Alias Born 12/09/2020

Re: None

Tuesday, 11/16/2021 9:20:30 AM

Tuesday, November 16, 2021 9:20:30 AM

Post# of 956
$OTLC: Oncotelic Announces Successful Completion of Safety Evaluation of First Cohort in OT-101/IL-2 Combination Trial for Treatment of Solid Tumor Cancers: https://oncotelic.irpass.com/Oncotelic-Announces-Successful-Completion-of-the-Safety-Evaluation-of-a-TGF-946--Inhibitor--OT-101--and-IL-2--Aldesleukin--in-Phase-1-Combination-Trial-in-Solid-Tumor-Cancers-11-16-2021
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLC News